Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases

Context. Numerous reports suggest an association between SGLT2 inhibitors and DKA. Since the use of these drugs for diabetes has increased dramatically, identification of patients at greatest risk of this life-threatening complication is essential. Objective. To describe the clinical and biochemical...

Full description

Saved in:
Bibliographic Details
Main Authors: G. A. Stamatiades, P. D’Silva, M. Elahee, G. M. Viana, A. Sideri-Gugger, S. K. Majumdar
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2023/6615624
Tags: Add Tag
No Tags, Be the first to tag this record!